Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Reduced intensity allogeneic BMT for myelodysplastic syndromes
NCT00045305Phase 2Completed
- Sponsor
- Eastern Cooperative Oncology Group
- Start
- Oct 2006
- Primary completion
- Feb 2014
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 2 trial of pentostatin in myelodysplastic syndrome (MDS), sponsored by Eastern Cooperative Oncology Group. Started Oct 2006; status: completed.
02
Drugs
pentostatin
03
Conditions
myelodysplastic syndrome (MDS)
Beyond the preview
Go deeper on NCT00045305.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00045305.